EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells


Biochemical & Biophysical Research Communications 131(2): 767-773
Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells
A 24 hr incubation of T-47D human breast cancer cells with R5020, a synthetic progestin, resulted in a 200-250% increase in the specific binding of human growth hormone (hCG) and epidermal growth factor (EGF) by these cells. This effect was specific for progestins in that similar responses were observed with progesterone, medroxyprogesterone acetate and ORG 2058 but no significant increases in hCG or EGF binding were observed in cells incubated with testosterone, estradiol or hydrocortisone. Increased binding was due to an increase in the concentration of receptors (hGH, control = 6,490 .+-. 500, progestin treated = 13,180 .+-. 3,270 sites/cell; EGF, control = 33,380 .+-. 7,410, progestin treated = 67,460 .+-. 20,330 sites/cell) while the affinity constants for the hormone-receptor interactions were unchanged by progestin treatment. The specific binding of insulin, calcitonin, transferrin and concanavalin A was unaffected by these treatments. It is concluded that expression of hGH and EGF receptors in this breast cancer cell line is regulated by progestins.

Accession: 006288286

PMID: 2996526

DOI: 10.1016/0006-291x(85)91305-1

Download PDF Full Text: Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells



Related references

Differential regulation of epidermal growth factor receptors by progestins and glucocorticoids in human breast cancer cells. Australian & New Zealand Journal of Medicine 16(1 SUPPL 1): 147, 1986

Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of alpha transforming growth factor epidermal growth factor epidermal growth factor receptor c fos and c myc genes. Proceedings of the American Association for Cancer Research Annual Meeting 32: 209, 1991

Mda 648 a human breast cancer cell line with a high number of epidermal growth factor receptors has an amplified epidermal growth factor receptor gene and is growth inhibited by epidermal growth factor. Biochemical & Biophysical Research Communications 128(2): 898-905, 1985

Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. Cancer Research 42(11): 4394-4398, 1982

Progestins induce down-regulation of insulin-like growth factor-I (IGF-I) receptors in human breast cancer cells: potential autocrine role of IGF-II. Molecular Endocrinology 5(5): 709-717, 1991

Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. Cancer Research 48(16): 4555-4560, 1988

Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin. Cancer Research 49(1): 112-116, 1989

Genomic organization and expression of receptors for estrogens progestins and epidermal growth factor in human breast cancer. Proceedings of the American Association for Cancer Research Annual Meeting 31: 223, 1990

Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines. International Journal of Cancer 44(4): 744-752, 1989

Differential signal transduction of epidermal-growth-factor receptors in hormone-dependent and hormone-independent human breast cancer cells. European Journal Of Biochemistry. 221(2): 631-637, 1994